These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Use of bisphosphonates in cancer patients. Body JJ; Coleman RE; Piccart M Cancer Treat Rev; 1996 Jul; 22(4):265-87. PubMed ID: 9025784 [No Abstract] [Full Text] [Related]
3. The evolving role of bisphosphonates. Theriault RL; Hortobagyi GN Semin Oncol; 2001 Jun; 28(3):284-90. PubMed ID: 11402438 [TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates--role in cancer therapies. Mehrotra B J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):19-26. PubMed ID: 19371811 [No Abstract] [Full Text] [Related]
5. [Bisphosphonates in the therapy of cancer patients]. Jantunen E; Kumpulainen E Duodecim; 1999; 115(1):27-32. PubMed ID: 11830857 [No Abstract] [Full Text] [Related]
6. Bisphosphonates in multiple myeloma: current status; future perspectives. Jantunen E; Laakso M Br J Haematol; 1996 Jun; 93(3):501-6. PubMed ID: 8652366 [No Abstract] [Full Text] [Related]
7. [Biphosphonates in oncology]. Khosravi Shahi P; Díaz Muñoz de la Espada V An Med Interna; 2005 Nov; 22(11):544-7. PubMed ID: 16454591 [TBL] [Abstract][Full Text] [Related]
8. [Progress in diagnosis and therapy: Hypercalcemia due to multiple myeloma and wide-spread neoplastic bone metastasis]. Abe M Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):675-80. PubMed ID: 17506303 [No Abstract] [Full Text] [Related]
9. [Role of diphosphonates in the therapy of osteolysis and malignant hypercalcemia]. Delmas PD; Charhon SA; Chapuy MC; Meunier PJ Rev Rhum Mal Osteoartic; 1984 Dec; 51(11):663-6. PubMed ID: 6523018 [No Abstract] [Full Text] [Related]
10. Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer. Paterson AH; Kanis JA; Powles TJ; McCloskey E; Hanson J; Ashley S Can J Oncol; 1995 Dec; 5 Suppl 1():54-7. PubMed ID: 8853526 [TBL] [Abstract][Full Text] [Related]
11. Bisphosphonates in the treatment of malignant bone disease. Berenson JR; Lipton A Annu Rev Med; 1999; 50():237-48. PubMed ID: 10073275 [TBL] [Abstract][Full Text] [Related]
12. Bisphosphonates in the prevention and treatment of bone metastases. Ramaswamy B; Shapiro CL Oncology (Williston Park); 2003 Sep; 17(9):1261-70; discussion 1270-2, 1277-8, 1280. PubMed ID: 14569853 [TBL] [Abstract][Full Text] [Related]
13. [Bisphosphonates and bone metastases]. Lortholary A; Jadaud E; Berthaud P Bull Cancer; 1999 Sep; 86(9):732-8. PubMed ID: 10519966 [TBL] [Abstract][Full Text] [Related]
14. Utility of bisphosphonates in treating bone metastases. Merlini G; Turesson I Med Oncol; 1996 Dec; 13(4):215-21. PubMed ID: 9152972 [TBL] [Abstract][Full Text] [Related]
15. Ibandronate in oncology. Burckhardt P Cancer; 1997 Oct; 80(8 Suppl):1696-8. PubMed ID: 9362439 [No Abstract] [Full Text] [Related]
16. The clinical and cost considerations of bisphosphonates in preventing bone complications in patients with metastatic breast cancer or multiple myeloma. McCloskey EV; Guest JF; Kanis JA Drugs; 2001; 61(9):1253-74. PubMed ID: 11511021 [TBL] [Abstract][Full Text] [Related]
17. Bisphosphonates' use in metastatic bone disease. Hubner RA; Houston SJ Hosp Med; 2005 Jul; 66(7):414-9. PubMed ID: 16025799 [TBL] [Abstract][Full Text] [Related]
18. Dichloromethylene diphosphonate action in hematologic and other malignancies. Canfield RE; Siris ES; Jacobs TP Bone; 1987; 8 Suppl 1():S57-62. PubMed ID: 2961356 [TBL] [Abstract][Full Text] [Related]
19. [Role of bisphosphonates in the treatment of tumoral osteolysis]. Claudepierre P; Puéchal X; Menkès CJ Ann Med Interne (Paris); 1995; 146(5):325-7. PubMed ID: 8526319 [No Abstract] [Full Text] [Related]
20. Bisphosphonate use in metastatic breast cancer: an audit assessing implementation of the British Association of Surgical Oncologists' guidelines. Abson C; James R; Smith C Clin Oncol (R Coll Radiol); 2004 Aug; 16(5):379. PubMed ID: 15341444 [No Abstract] [Full Text] [Related] [Next] [New Search]